Previous Article | Next Article ![]()
Journal of Bacteriology, July 2008, p. 4460-4469, Vol. 190, No. 13
0021-9193/08/$08.00+0 doi:10.1128/JB.00270-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Milan, Italy,1 Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544,2 Dipartimento di Chimica Organica e Biochimica, Università di Napoli Federico II, Naples, Italy,3 Dipartimento di Scienze biomolecolari e Biotecnologie, Università degli Studi di Milano, Milan, Italy4
Received 22 February 2008/ Accepted 8 April 2008
|
|
|---|
|
|
|---|
The biogenesis of the OM implies that the individual components are transported from the site of synthesis to their final destination outside the IM by crossing both hydrophilic and hydrophobic compartments. The machinery and the energy source that drive this process are not yet understood.
The lipid A-core moiety and the O-antigen repeat units are synthesized at the cytoplasmic face of the IM and are separately exported via two independent transport systems, namely, the O-antigen transporter Wzx (13, 17) and the ATP binding cassette (ABC) transporter MsbA that flips the lipid A-core moiety from the inner leaflet to the outer leaflet of the IM (12, 28, 45). O-antigen repeat units are then polymerized in the periplasm by the Wzy polymerase and ligated to the lipid A-core moiety by the WaaL ligase (reference 29 and references therein). Escherichia coli K-12 LPS is missing the O antigen, as an IS5 insertion disrupts its synthesis (18). Very recently, a modified LPS in which repeating units of colanic acid, a cell surface polysaccharide synthesized by enteric bacteria in the presence of envelope-damaging stresses (42), are ligated to the core oligosaccharide in a WaaL-dependent manner has been described (21).
How LPS reaches the OM is less well understood. A protein complex in the OM of E. coli composed of LptD (formerly Imp), an essential β-barrel OM protein (6), and LptE (formerly RlpB), an essential OM lipoprotein, has recently been implicated in LPS assembly (43). Depletion of either protein results in similar OM biogenesis defects, including increased LPS levels, abnormal membrane structures, and activation of the OM enzyme PagP (43). These findings indicate that the LptD/LptE complex is responsible for LPS assembly at the outer surface of the OM (43). LptD has also been shown to be required for proper transport of LPS to the cell surface of N. meningitidis (5). This conclusion was based on loss of surface accessibility of LPS to neuraminidase and loss of lipid A modification by the OM deacylase PagL (5).
More recently, two additional essential E. coli proteins, LptA and LptB (formerly YhbN and YhbG, respectively), have been implicated in LPS transport to the OM (35). LptA is a periplasmic protein (38), whereas LptB, a cytoplasmic protein possessing the ABC signature, has been found to be associated with the IM (40). Mutants depleted of LptA and/or LptB have abnormal membrane structures in the periplasm, produce an anomalous LPS form characterized by ladderlike banding of higher-molecular-weight species, and, more importantly, do not transport de novo-synthesized LPS to the OM (35). Based on these findings, it has been suggested that LptA and LptB, together with as-yet-unidentified transmembrane partners, may form a membrane-associated complex required for LPS transport across the periplasm (35).
In this paper we provide evidence that LptA, LptB, LptD, LptE, and YrbK (renamed LptC), an essential IM protein characterized here, are all members of the same LPS transport machinery. In fact, depletion of any of these proteins blocks the LPS assembly pathway in nearly the same fashion, which results in very similar phenotypes. Moreover, the location of at least one of these five proteins in every cellular compartment suggests a model for how the LPS assembly pathway is organized and ordered in space.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
waaL was inactivated by using a
-Red recombineering technique adapted from previously described methods (10), as described above. A chloramphenicol cassette was engineered into the waaL gene by PCR amplifying the pKD3 plasmid (11) with primer FL9 (5'-ATGCTAACATCCTTTAAACTTCATTCATTGAAACCTTACACTCTGAAATCGTGTAGGCTGGAGCTGCTTC-3') and primer FL10 (5'-TTAATTAATTGTATTGTTACGATTATTAATGACGAGTAAGAGGACTATAGCATATGAATATCCTCCTTAG-3'). The PCR product was introduced into DY378 by using a standard electroporation technique. The waaL::cam locus was transferred into FL905, FL907, AM661, and AM679 by P1 transduction (34). Bacteria were grown in LD broth (33). When required, 0.2% L-arabinose (as an inducer of the araBp promoter), 0.2% glucose, 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for overexpression of LptC with a C-terminal His6 tag (LptC-H) or 1 mM IPTG, 100 µg/ml ampicillin, 50 µg/ml kanamycin, and 25 µg/ml chloramphenicol were added. Solid media were the same as the media described above except that they contained 1% agar.
Plasmid pGS108 expresses LptC-H under control of a ptac (IPTG-inducible) promoter. It was constructed by cloning the lptC open reading frame obtained by PCR amplification of MG1655 DNA with primers AP54 (5'-CGAGAGGAATTCACCATGAGTAAAGCCAGACGTTGGG-3') and AP63 (5'-GTGATCACATCTAGATCAGTGGTGGTGGTGGTGGTGAGGCTGAGTTTGTTTGTTTTG-3'). The PCR product was digested with EcoRI and XbaI and ligated to pGS100 cut with the same enzymes. The EcoRI-XbaI insert in pGS108 was verified by DNA sequencing.
LPS extraction and analysis by immunoblotting. Bacterial cultures grown at 30°C in LD medium or LD medium with arabinose to an optical density at 600 nm (OD600) of 0.2 were harvested by centrifugation, washed in LD medium, and diluted 250- or 20-fold in LD medium with or without arabinose. Samples at an OD600 of 2 were taken at different time points, and LPS was extracted from the cell pellets by a mini phenol-water extraction procedure as described previously (30). Briefly, the cells were resuspended in water and pelleted by centrifugation (5 min, 10,000 x g) to remove the exopolysaccharides. The pellet was resuspended in 0.5 ml phosphate buffer (pH 7) and thoroughly vortexed; 0.5 ml phenol equilibrated with 0.1 M Tris-HCl at pH 5.5 was added, and the suspension was vortexed. The tubes were placed in a 65°C heating block for 15 min, thoroughly vortexed every 5 min, and then cooled in ice. After centrifugation (5 min, 10,000 x g), the water phase was removed, dialyzed (2,000-molecular-weight cutoff) against phosphate buffer (pH 7), and dried under a vacuum. Air-dried material was then dissolved in 30 µl sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. LPS was separated by Tricine-SDS-PAGE as described previously (37). LPS were transferred onto a nitrocellulose membrane (Whatman, Inc.) at 100 V for 1 h using an electroblotting apparatus (Bio-Rad) and were immunodetected using a 1:3,000 dilution of the anti-LPS WN1 222-5 monoclonal antibody (HyCult Biotechnology b.v.).
Analysis of LPS composition and analytical methods. The LPS fraction was separated using gel permeation chromatography on a Sephadex G-100 column (100 by 3 cm) eluted with a buffer consisting of 0.2 M NaCl, 0.25% deoxycholate, 1 mM EDTA, 0.02% NaN3, and 10 mM Tris in water (pH 8.0) at 20°C. The results were monitored with a differential refractometer (Knauer), and 3-ml fractions were collected and were successively dialyzed against 0.2 M NaCl, 1 mM EDTA, 10 mM Tris-HCl, 0.02% (wt/vol) NaN3 buffer for 3 days, then against 0.2 M NaCl buffer for 3 days, and finally against water for 3 days. Each fraction was analyzed by an SDS-PAGE procedure as described previously (37). Determination of sugar residues and of their absolute configurations, gas-liquid chromatography (GLC), and GLC-mass spectrometry (MS) were all carried out as described previously (22, 23). Monosaccharides were identified as acetylated O-methyl glycoside derivatives. After methanolysis (2 M HCl-methanol, 85°C, 24 h) and acetylation with acetic anhydride in pyridine (85°C, 30 min), the sample was analyzed by GLC-MS. A linkage analysis was carried out by methylation of the complete LPS fraction and also of the dephosphorylated LPS as described previously (8), and identical results were obtained. The sample was hydrolyzed with 4 M trifluoroacetic acid (100°C, 4 h), carbonyl reduced with NaBD4, carboxy methylated, carboxyl reduced, acetylated, and analyzed by GLC-MS. Oligosaccharide OS1 was obtained by hydrolysis of LPS with acetate buffer at pH 4.5 at 100°C for 2 h (22).
NMR spectroscopy.
For structural assignment, one-dimensional and two-dimensional 1H nuclear magnetic resonance (NMR) spectra were recorded using a solution consisting of 0.3 mg in 0.5 ml of D2O at 300 K and pD 7 (uncorrected value) with a Bruker 600 DRX spectrometer equipped with a cryoprobe. Spectra were calibrated with internal acetone (
H 2.225,
C 31.45). 31P NMR experiments were carried out using a Bruker DRX-400 spectrometer, and aqueous 85% phosphoric acid was used as the external reference (0.00 ppm). A rotating frame Overhauser enhancement spectroscopy experiment was performed using data sets of 4,096 x 1,024 points, and 64 scans were acquired with a mixing time of 200 ms; a double quantum-filtered phase-sensitive correlation spectroscopy experiment was performed with an acquisition time of 0.258 s using data sets of 4,096 x 1,024 points, and 128 scans were acquired; and a total correlation spectroscopy experiment was performed with a spinlock time of 100 ms using data sets of 4,096 x 1,024 points, and 64 scans were acquired. In all homonuclear experiments the data matrix was zero filled in the F1 dimension to obtain a matrix of 4,096 x 2,048 points and was resolution enhanced in both dimensions by a shifted sine-bell function before Fourier transformation. Coupling constants were determined on a first-order basis using two-dimensional phase-sensitive double quantum-filtered correlation spectroscopy (27). The heteronuclear single quantum coherence and heteronuclear multiple bond correlation experiment spectra were measured in the 1H-detected mode with proton decoupling in the 13C (or 31P) domain, using data sets of 2,048 x 512 points, and 64 scans were acquired for each t1 value. The experiments were carried out in the phase-sensitive mode (38) 1H,13C heteronuclear multiple bond correlation was optimized for a 6-Hz coupling constant, and 1H,31P heteronuclear single quantum coherence was optimized for an 8-Hz coupling constant. In all the heteronuclear experiments the data matrix was extended to 2,048 x 1,024 points using forward linear prediction extrapolation.
MS. Negative Reflectron matrix-assisted laser desorption ionization (MALDI) spectra were recorded using a Voyager DE STR instrument (Applied Biosystems, Framingham, MA). The MALDI matrices were prepared by dissolving 20 mg of 2,3-dihydroxybenzoic acid in 1 ml of acetonitrile-water (90:10, vol/vol). Typically, 1 µl of matrix was applied to the metallic sample plate, and 1 µl of analyte was then added. The acceleration and reflector voltages were set up as follows: a target voltage of 20 kV and the first grid at 95% of the target voltage, with delayed extraction at 600 ns to obtain the best signal-to-noise ratios and the best possible isotopic resolution. Each spectrum represents the sum of 1,500 laser pulses from randomly chosen spots per sample position. All analyses were conducted in triplicate.
Raw data were analyzed using the computer software provided by the manufacturers and are expressed as monoisotopic masses.
[3H]GlnNAc pulse-labeling and cell fractionation. Mutants were grown in LD medium with arabinose to an OD600 of 0.2 at 30°C in the presence of 0.2% N-acetylglucosamine (GlnNAc) to induce GlnNAc uptake. Cells were then harvested, washed in LD medium, diluted 200- and 50-fold (FL905 and FL907) and 20-fold (AM689 and AM661) in 50 and 100 ml fresh medium with and without arabinose, respectively, and incubated with aeration at 30°C. N-Acetyl[3H]glucosamine ([3H]GlnNAc) pulse-labeling (see below) of mutants grown with arabinose was performed when the cultures reached an OD600 of 0.3 to 0.4, whereas depleted cultures grown without arabinose were labeled 1 h after the cultures reached the maximal OD600 (OD600 between 0.2 and 0.4). [3H]GlnNAc pulse-labeling was performed by adding [3H]GlnNAc (1.5 µCi ml–1) to a culture, followed by a chase after 2 min with 0.4% nonradioactive GlnNAc. After a 5-min chase, cells were chilled in ice and harvested by centrifugation. IM and OM were separated by discontinuous sucrose density gradient centrifugation of a total membrane fraction obtained by spheroplast lysis as described previously (26). Step gradients were prepared by layering 2 ml each of 50, 45, 40, 35, and 30% (wt/vol) sucrose solutions over a 55% sucrose cushion (0.5 ml).
Fractions (300 µl) were collected from the top of the gradient, and 16 µl of each fraction was transferred onto a nitrocellulose membrane at 100 V for 1 h or at 12 V overnight in an electroblotting apparatus (PBI) for protein profile analysis. The IM profile of the fractions was determined by immunoblotting using a 1:10,000 dilution of anti-LptD polyclonal antibody which cross-reacts with an 55-kDa IM protein (43). The distribution of the OM on the nitrocellulose membrane was immunodetected using a 1:5,000 dilution of anti-LamB polyclonal antibody.
To estimate the LPS contents in the gradient fractions, 16-µl portions of the fractions were separated by Tricine-SDS-PAGE and immunoblotting performed as described above.
To estimate 3H incorporation, 50 µl of each fraction dissolved in 4 ml scintillation liquid (Ready safe; Beckman Coulter) was counted with a liquid scintillation counter (LS6500; Beckman).
Cellular localization of LptC. Cultures of BW25113 containing plasmid pGS108 were grown in LD medium to an OD600 of 0.7, and LptC-H was induced for 2 h with 0.5 mM IPTG. Periplasmic, cytoplasmic, IM, and OM fractions were prepared as described previously (25). Equal volumes of the fractions were fractionated by 10% SDS-PAGE. The tagged protein was detected by Western blotting using anti-His6 monoclonal antibody (Roche). An antibody against the IM protein YidC (19) was used as a control for good fractionation.
Electron microscopy. Samples used for electron microscopy were prepared using the method of Ogura et al. (24). Thin (70-nm) sections were obtained by using a diamond knife in a Leica UC6 ultramicrotome and were observed at 80 kV with a Zeiss 912AB transmission electron microscope equipped with an Omega energy filter. Micrographs were captured by using a digital camera obtained from Advanced Microscopy Techniques and were saved as TIFF files onto a Dell personal computer.
|
|
|---|
The lptC gene encodes a 191-amino-acid protein (predicted molecular mass, 21.7 kDa). Primary sequence analysis revealed the presence of one transmembrane domain. To determine the subcellular localization of LptC, we constructed a tagged version of the protein carrying a C-terminal His6 tag (LptC-H) under control of the IPTG-inducible ptac promoter (plasmid pGS108). This construct produced a functional LptC-H protein as it complemented the arabinose-dependent phenotype of BB-3 (data not shown). Periplasmic, cytoplasmic, IM, and OM fractions from IPTG-induced and noninduced BW25113/pGS108 were prepared as described previously (25) and analyzed by Western blotting using anti-His6 tag monoclonal antibodies. As shown in Fig. 1, LptC-H was detectable only in the IM fraction. An antibody against the IM protein YidC (19) was used as a fractionation control. Experiments described below verified that LptC functions in LPS transport. Thus, we have identified an essential LPS transport component in every cellular compartment: LptB in the cytoplasm, LptC in the IM, LptA in the periplasm, and LptD and LptE in the OM.
![]() View larger version (16K): [in a new window] |
FIG. 1. Subcellular localization of LptC. BW25113/pGS108 cells were induced with IPTG, disrupted, and fractionated as described in Materials and Methods. Samples of periplasmic (P), cytoplasmic (S), IM, and OM fractions were analyzed by SDS-PAGE and Western blotting with anti-His6 antibodies (upper panel). The same fractions were analyzed with anti-YidC antibodies as an IM marker (lower panel). T, total protein fraction.
|
Structural abnormalities in cells depleted of LptA-LptB LptC, LptD, and LptE. Mutant cells depleted of LptA-LptB, LptD, and LptE exhibit striking alterations in envelope structure, such as abnormal membrane structures and accumulation of "extra" membrane material in the periplasm (35, 43). The isogenic depletion strains were grown to exponential phase and then shifted to media lacking arabinose. Samples were taken 300 min after the shift to depletion conditions and then processed for electron microscopy as described in Material and Methods. As shown in Fig. 2B, depleted cells of all strains contained strikingly similar multilayer membranous bodies that protruded into the periplasmic space that were absent in the nondepleted control. These data strongly implicate LptC in LPS biogenesis, and they suggest that there are similar defects in LPS transport in all of the depletion strains.
![]() View larger version (80K): [in a new window] |
FIG. 2. Cell morphology upon depletion of LptA-LptB, LptE, LptD, and LptC. Cells grown in the presence (+) or in the absence (–) of arabinose were prepared for electron microscopy as described in Materials and Methods. Scale bars, 0.5 µm.
|
![]() View larger version (58K): [in a new window] |
FIG. 3. Membrane fractionation of cells depleted of LptA-LptB, LptD, LptE, and LptC. FL907, AM661, AM689, and FL905 cultures were grown with arabinose to an OD600 of 0.2, harvested, and resuspended in an arabinose-supplemented or arabinose-free medium. About 1 h after the cultures had reached the maximal OD600 (OD600 between 0.2 and 0.6), cells were pulse-labeled for 2 min with [3H]GlnNAc and chased for 5 min with 0.4% nonradioactive GlnNAc; the nondepleted cultures were pulse-labeled when the same OD600 was reached, as described in Materials and Methods. Total membranes prepared from cells were fractionated by sucrose density gradient. Fractions were collected from the top of the gradient and immunoblotted using antibodies recognizing LPS, LamB, and a 55-kDa IM protein as indicated. Fractions were also analyzed for total incorporated radioactivity. The panels on the left show the percentages of the total incorporated radioactivity for nondepleted ( ) and depleted ( ) mutant cells. The panels on the right show the LamB and OmpA profiles of nondepleted (+ ara) and depleted (– ara) mutant cells. The OmpA protein cross-reacts with the LamB antibody. (A) FL907 cells depleted and not depleted of LptA-LptB. (B) AM661 cells depleted and not depleted of LptD. (C) AM689 cells depleted and not depleted of LptE. (D) FL905 cells depleted and not depleted of LptC.
|
In summary, the membrane fractionation patterns of all of the depletion strains grown under permissive conditions were quite similar. The OM equilibrated around fractions 19 to 21, where most of the radioactivity and total LPS were found (Fig. 3). In contrast, in all depleted strains the radioactivity appeared in two lighter peaks equilibrating around fractions 7 and 13, and a substantial amount of LPS was shifted toward lighter fractions (fractions 1 to 17), showing the ladderlike banding of high-molecular-weight species also observed previously (35). These data indicate that under depletion conditions de novo-synthesized LPS does not reach the OM and accumulates in the lighter part of the gradient in a modified form.
Altogether, these results suggest (i) that LptA, LptB, LptC, LptD, and LptE operate in the same pathway (namely, the transport of de novo-synthesized LPS to the OM) and (ii) that when this pathway is impaired by the loss of any one of these proteins, LPS-incorporated radioactivity and an anomalous form of LPS, visible as a ladder of bands migrating more slowly than the native LPS, accumulate in light membrane fractions.
Colanic acid is ligated to LPS in cells depleted of LptA-LptB. In order to elucidate the chemical structure of the high-molecular-mass, ladderlike bands observed when LPS transport is impaired, we isolated the LPS fraction produced by cells depleted of LptA-LptB and carried out a structural analysis. As the high-molecular-mass species represent a very small fraction of the total LPS, they were purified by gel permeation chromatography with sodium deoxycholate. Using gel filtration with a denaturing agent, we were able to separate the various LPS molecular species into eight different fractions (see Fig. S1 in the supplemental material). The fraction with the greatest relative abundance of high-molecular-weight LPS species was subjected to mild hydrolysis with acetate buffer to split the lipid A from the core oligosaccharide fraction (fraction OS1).
The OS1 fraction was subjected to full structural elucidation by chemical analysis, MS, and NMR spectroscopy, and all data converged to indicate the presence of a colanic acid repeating unit attached to the outer core region of the LPS at O-7 of the heptose residue, as described previously for a mucoid mutant of E. coli K-12 defective in KDO biosynthesis (21). Monosaccharide analyses showed the expected residues of the core region of LPS and colanic acid residues. In order to confirm the structural hypothesis described above, the oligosaccharide portion was analyzed by MALDI-time of flight MS and NMR spectroscopy. The MALDI-MS spectrum (Fig. 4A) showed a main molecular ion at 1796.7 that could be assigned to the complete core region of wild-type E. coli K-12 LPS, as previously observed (21). In agreement, peaks related to the same glycoform either lacking a phosphate group or possessing an additional 2-amino-ethyl phosphate residue were also present. At higher molecular weights of the same spectrum an ion peak at m/z 2834.8 was present, which was in agreement with the presence of the same core glycoform that also possessed a bis-acetylated colanic acid repeating unit (
m/z 1038) lacking a pyruvate group. Other minor peaks were also present that could be assigned to the same glycoform that in addition possessed a 2-amino-ethyl phosphate residue (m/z 2957.6) and/or lacked a phosphate (m/z 2754.8) or possessed a further pyruvate group (m/z 2904.6), which was not stoichiometrically cleaved by 1% acetate. Other repeating units of colanic acid were not visualized by MALDI-MS because of their very small amounts, even though they were detected by SDS-PAGE (see Fig. S1 in the supplemental material).
![]() View larger version (16K): [in a new window] |
FIG. 4. (a) MALDI-MS spectrum of the product OS1. The main molecular ion at m/z 1796.7 consists either of hexa-acylated lipid A or the complete core region of wild-type E. coli K-12 LPS, whereas the higher-molecular-mass ion peaks can be assigned to the same oligosaccharide that in addition bears one or more bis-acetylated colanic acid repeating units ( m/z 1038) lacking a pyruvate group. (b) 1H NMR spectrum of the O-deacetylated OS1 product, in which the great heterogeneity of the sample due to nonstoichiometric substitutions and reducing KDO arrangements is evident. (Inset) Anomeric assignments of the colanic acid single repeating unit as shown in Table S1 in the supplemental material. (c) Repeating unit of colanic acid. Residues are -configured unless stated otherwise.
|
O-antigen ligase modifies LPS in cells depleted of LptA-LptB LptC, LptD, and LptE. As both colanic acid and the O-antigen are ligated to the L-glycero-D-manno-heptose residue of the LPS outer core (13), we tested the possibility that the O-antigen ligase WaaL was responsible for this LPS modification. Disruptions of the waaL gene were generated in FL905, FL907, AM661, and AM679 mutant backgrounds, and the LPS profiles were analyzed for all strains grown with and without arabinose. As shown in Fig. 5, cells depleted of each protein displayed the same ladderlike banding of high-molecular-mass LPS species in total LPS preparations, confirming that this anomalous LPS form is produced when transport of LPS to the OM is impaired. Disruptions of waaL in each strain completely abolished the formation of the higher-molecular-weight LPS bands in cells depleted of LptE, LptD, LptA-LptB, and LptC (Fig. 5A, B, C, and D, respectively), indicating that colanic acid is dependent upon the WaaL O-antigen ligase for linkage to the LPS core.
![]() View larger version (74K): [in a new window] |
FIG. 5. WaaL dependence of anomalous LPS production. The strains carrying a functional O-antigen ligase (+ waaL) or in which the O-antigen ligase is disrupted (– waaL) were grown with arabinose (+ ara) or without arabinose (– ara) as described in Material and Methods. The LPS profile was determined by Western blotting using anti-LPS WN1 222-5 antibodies. (A) LptE depletion, 300 min. (B) LptD depletion, 360 min. (C) LptAB depletion, 240 min. (D) LptC depletion, 360 min.
|
|
|
|---|
LptC, the newly identified member of the LPS transport machinery, is an IM protein that could be part of a complex together with LptB, the cytoplasmic ABC component of a transporter, and the periplasmic protein LptA (35). LptB, which has been shown to be in a 140-kDa IM complex (40), could provide the energy from ATP hydrolysis to extract LPS from the periplasmic surface of the IM and deliver it to the LptD/LptE complex in the OM. As secondary structure prediction of LptC showed that there is only one putative transmembrane helix, additional integral membrane components may still be missing in this system. Very recently, two essential IM proteins, LptG and LptF (formerly YjgP and YjgQ, respectively), were identified and proposed to be the missing transmembrane components of the ABC transporter that together with LptB function to extract LPS from the IM en route to the OM (31). LptD and LptE could then receive the LPS at the inner leaflet of the OM, flipping the LPS across the OM or in both of these processes (43). The five proteins described in this study operate in the LPS assembly pathway downstream of MsbA and are located in each of the cellular compartments of a gram-negative bacterium, thus suggesting how the components are organized and ordered in space, as well as the likely order of the flow of LPS molecules from the IM to the cell surface (Fig. 6). We show here that if this assembly pathway is broken at any place, LPS accumulates at the outer surface of the IM. The buildup of LPS molecules in this location allows modification with colanic acid in a reaction catalyzed by the WaaL ligase, an enzyme located in the IM facing the periplasm. This LPS modification has recently been reported by Meredith and coworkers for an E. coli mutant (KPM22) that is deficient in KDO synthesis and overproduces the YhjD flippase (21). Our data show that the higher-molecular-weight species of LPS that accumulate in the depletion strains are located largely in the IM. We believe that the extra LPS molecules form protrusions that extend into the periplasm, accounting for the extra membranes observed by electron microscopy in cells depleted of LptA-LptB, LptC, LptE, and LptD in this and previous studies (35, 43). In support of this hypothesis, it can be noted that for mutants defective in the MsbA flippase electron micrographs show membrane invaginations that extend into the cytoplasm, probably because of the tension created by the buildup of LPS on the inner surface of the IM (12). In any case, the data described above suggest that the appearance of LPS modified with colanic acid is diagnostic for defects in LPS transport occurring downstream of the MsbA-mediated flipping of the lipid A-core moiety to the periplasmic face of the IM.
![]() View larger version (54K): [in a new window] |
FIG. 6. Model for the transport of LPS. The lipid A-core moiety is synthesized in the cytoplasm and flipped over the IM by MsbA. LptA, LptB, and LptC are part of a protein machine that transports LPS across the periplasm to the OM. The two additional transmembrane components recently identified (31), LptF and LptG, are postulated to complete the IM-bound ABC transporter. The LptD/LptE complex is thought to mediate the insertion of the newcomer LPS into the OM. The former names of the proteins are indicated in parentheses.
|
T.J.S. and F.K.L. were supported by NIGMS award GM34821. P.S. was supported by an Ingenio-Finlombarda fellowship. This work was partially supported by Fondazione Cariplo grant 2005.1076/10.4878.
Published ahead of print on 18 April 2008. ![]()
Supplemental material for this article may be found at http://jb.asm.org/. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»